disease 3,474 words KG: ent-dise-9422fb45
Contents

semantic-dementia

Disease Info
PrevalenceApproximately 2–3 per 100,000 (representing ~20–30% of Frontotemporal Dementia cases)
Age at onsetTypically 55–65 years (range 40–80); slightly younger average onset than alzheimers
SexSlight male predominance in some series (M:F ~1.3:1)
Proportion of PPAsvPPA accounts for approximately 20–30% of all PPA cases
Proportion of FTDRepresents ~20–25% of Frontotemporal Dementia cases
SurvivalMedian 8–12 years from symptom onset; slower progression than behavioral variant FTD (bvFTD)
Family historyMost cases (~90%) have no significant family history of dementia or neurodegenerative disease [@landinromero2016]
Genetic mutationsRarely associated with known FTD genes; occasional cases linked to:
Distributiontdp-43 type C inclusions are most dense in **cortical layer 2** of the anterior and inferior temporal neocortex [@josephs2011], [@spinelli2017]
Frequency75–90% of svPPA cases show tdp-43 type C; remainder show tau] pathology (~5–10%, usually Pick's disease) or alzheimers pathology (~5%)
Anterior temporal lobe (ATL) atrophyBilateral but asymmetric, with the left ATL more severely affected in typical svPPA cases presenting with language symptoms
Specific subregionsThe temporal pole, anterior fusiform gyrus, anterior inferior and middle temporal gyri, and anterior hippocampus are most severely affected
DatabasesOMIMOrphanetClinicalTrialsPubMed

Knowledge Graph

Related Hypotheses (12)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Circadian-Synchronized Proteostasis Enhancement
Score: 0.58
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Circadian Clock-Autophagy Synchronization
Score: 0.55
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Related Analyses (10)

Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived

Related Experiments (2)

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40